≡

Coagulation Factor II (F2)

[Edit]

FII; TM; PT; Thrombin; Prothrombin; Pro-Thrombin; Activation peptide fragment 1; Activation peptide fragment 2

Coagulation Factor II (F2)
CCC A820
HGNC 3535
MGI 88380
PubMed 2607889
RGD 61996
UniProt P00734
Wiki Thrombin

Thrombin (activated Factor II [IIa]) also commonly called pro-thrombin is a coagulation protein in the blood stream that has many effects in the coagulation cascade. It is a serine protease (EC 3.4.21.5) that converts soluble fibrinogen into insoluble strands of fibrin, as well as catalyzing many other coagulation-related reactions. The Thrombin (prothrombin) gene is located on the eleventh chromosome (11p11-q12). The molecular weight of prothrombin is approximately 72000 gmol-1. The catalytic domain is released from prothrombin fragment 1.2 to create the active enzyme thrombin, which has a molecular weight of 36000 gmol-1.There are an estimated 30 people in the world that have been diagnosed with the congenital form of Factor II deficiency, which should not be confused with a mutation of prothrombin.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA820Hu01 Recombinant Coagulation Factor II (F2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA820Hu02 Recombinant Coagulation Factor II (F2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA820Hu03 Recombinant Coagulation Factor II (F2) Positive Control; Immunogen; SDS-PAGE; WB.
NPA820Hu01 Native Coagulation Factor II (F2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA820Hu01 Polyclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
MAA820Hu22 Monoclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
MAA820Hu21 Monoclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
MAA820Hu23 Monoclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
MAA820Hu24 Monoclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
PAA820Hu02 Polyclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
MAA820Hu25 Monoclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
MAA820Hu27 Monoclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
MAA820Hu29 Monoclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
Assay Kits SEA820Hu ELISA Kit for Coagulation Factor II (F2) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA820Hu CLIA Kit for Coagulation Factor II (F2) Chemiluminescent immunoassay for Antigen Detection.
AEA820Hu ELISA Kit for Anti-Coagulation Factor II Antibody (Anti-F2) Enzyme-linked immunosorbent assay for Antibody Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA820Mu01 Recombinant Coagulation Factor II (F2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA820Mu03 Recombinant Coagulation Factor II (F2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA820Mu02 Recombinant Coagulation Factor II (F2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA820Mu01 Polyclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
PAA820Mu02 Polyclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
PAA820Mu03 Polyclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
LAA820Mu71 Biotin-Linked Polyclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC.
LAA820Mu81 FITC-Linked Polyclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IF.
MAA820Mu22 Monoclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
Assay Kits SEA820Mu ELISA Kit for Coagulation Factor II (F2) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA820Ra01 Recombinant Coagulation Factor II (F2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA820Ra02 Recombinant Coagulation Factor II (F2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA820Ra03 Recombinant Coagulation Factor II (F2) Positive Control; Immunogen; SDS-PAGE; WB.
APA820Ra02 Active Coagulation Factor II (F2) Cell culture; Activity Assays.
Antibodies PAA820Ra01 Polyclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
PAA820Ra02 Polyclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
MAA820Ra22 Monoclonal Antibody to Coagulation Factor II (F2) WB,IHC
LAA820Ra71 Biotin-Linked Polyclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC.
LAA820Ra81 FITC-Linked Polyclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IF.
PAA820Ra03 Polyclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
MAA820Ra21 Monoclonal Antibody to Coagulation Factor II (F2) WB
MAA820Ra23 Monoclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
MAA820Ra24 Monoclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
MAA820Ra25 Monoclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
MAA820Ra27 Monoclonal Antibody to Coagulation Factor II (F2) WB; IHC
MAA820Ra29 Monoclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
Assay Kits SEA820Ra ELISA Kit for Coagulation Factor II (F2) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Sus scrofa; Porcine (Pig)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Coagulation Factor II (F2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Coagulation Factor II (F2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Coagulation Factor II (F2) Polyclonal Antibody Customized Service Offer
Assay Kits SEA820Po ELISA Kit for Coagulation Factor II (F2) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Bos taurus; Bovine (Cattle)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA820Bo01 Recombinant Coagulation Factor II (F2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA820Bo02 Recombinant Coagulation Factor II (F2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA820Bo01 Polyclonal Antibody to Coagulation Factor II (F2) WB; IHC; ICC; IP.
Assay Kits SEA820Bo ELISA Kit for Coagulation Factor II (F2) Enzyme-linked immunosorbent assay for Antigen Detection.
  1. "Nucleotide sequence of the gene for human prothrombin."Biochemistry 26:6165-6177(1987) [PubMed] [Europe PMC] [Abstract]
  2. "Prothrombin Shanghai: hypoprothrombinaemia caused by substitution of Gla29 by Gly."Haemophilia 10:94-97(2004) [PubMed] [Europe PMC] [Abstract]
  3. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin."Biochemistry 22:2087-2097(1983) [PubMed] [Europe PMC] [Abstract]
  6. "Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation: evidence of activation peptide of human prothrombin."Urol. Res. 22:45-50(1994) [PubMed] [Europe PMC] [Abstract]
  7. "Amino acid sequence of human prothrombin fragments 1 and 2."Proc. Natl. Acad. Sci. U.S.A. 74:1969-1972(1977) [PubMed] [Europe PMC] [Abstract]
  8. "Primary structure of human prethrombin 2 and alpha-thrombin."J. Biol. Chem. 252:4942-4957(1977) [PubMed] [Europe PMC] [Abstract]
  9. "Mechanism of inhibition of activated protein C by protein C inhibitor."J. Biochem. 95:187-195(1984) [PubMed] [Europe PMC] [Abstract]
  10. "Prothrombin fragment 1 X 2 X 3, a major product of prothrombin activation in human plasma."J. Biol. Chem. 261:13210-13215(1986) [PubMed] [Europe PMC] [Abstract]
  11. "Synthetic peptides bind to high-affinity thrombin receptors and modulate thrombin mitogenesis."Pept. Res. 1:65-73(1988) [PubMed] [Europe PMC] [Abstract]
  12. "Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester."Am. J. Reprod. Immunol. 46:124-131(2001) [PubMed] [Europe PMC] [Abstract]
  13. "Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls."Arch. Neurol. 61:1652-1661(2004) [PubMed] [Europe PMC] [Abstract]
  14. "Screening for N-glycosylated proteins by liquid chromatography mass spectrometry."Proteomics 4:454-465(2004) [PubMed] [Europe PMC] [Abstract]
  15. "rhBMP-2, rhVEGF(165), rhPTN and thrombin-related peptide, TP508 induce chemotaxis of human osteoblasts and microvascular endothelial cells."J. Orthop. Res. 23:680-685(2005) [PubMed] [Europe PMC] [Abstract]
  16. "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry."J. Proteome Res. 4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract]
  17. "Thrombin peptide Chrysalin stimulates healing of diabetic foot ulcers in a placebo-controlled phase I/II study."Wound Repair Regen. 15:23-34(2007) [PubMed] [Europe PMC] [Abstract]
  18. "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
  19. "A strategy for precise and large scale identification of core fucosylated glycoproteins."Mol. Cell. Proteomics 8:913-923(2009) [PubMed] [Europe PMC] [Abstract]
  20. "Enrichment of glycopeptides for glycan structure and attachment site identification."Nat. Methods 6:809-811(2009) [PubMed] [Europe PMC] [Abstract]
  21. "Human urinary glycoproteomics; attachment site specific analysis of N-and O-linked glycosylations by CID and ECD."Mol. Cell. Proteomics 0:0-0(2011) [PubMed] [Europe PMC] [Abstract]
  22. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  23. "The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment."EMBO J. 8:3467-3475(1989) [PubMed] [Europe PMC] [Abstract]
  24. "Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition."EMBO J. 9:2361-2365(1990) [PubMed] [Europe PMC] [Abstract]
  25. "The structure of a complex of recombinant hirudin and human alpha-thrombin."Science 249:277-280(1990) [PubMed] [Europe PMC] [Abstract]
  26. "Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms."Protein Sci. 2:1630-1642(1993) [PubMed] [Europe PMC] [Abstract]
  27. "Crystallographic structure of human gamma-thrombin."J. Biol. Chem. 269:22000-22006(1994) [PubMed] [Europe PMC] [Abstract]
  28. "The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin."EMBO J. 16:2977-2984(1997) [PubMed] [Europe PMC] [Abstract]
  29. "Unexpected crucial role of residue 225 in serine proteases."Proc. Natl. Acad. Sci. U.S.A. 96:1852-1857(1999) [PubMed] [Europe PMC] [Abstract]
  30. "Inhibition of human alpha-thrombin by a phosphonate tripeptide proceeds via a metastable pentacoordinated phosphorus intermediate."J. Mol. Biol. 311:549-555(2001) [PubMed] [Europe PMC] [Abstract]
  31. "Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitors."Org. Biomol. Chem. 4:2364-2375(2006) [PubMed] [Europe PMC] [Abstract]
  32. "Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin."J. Am. Chem. Soc. 129:10648-10649(2007) [PubMed] [Europe PMC] [Abstract]
  33. "Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles."Bioorg. Med. Chem. Lett. 18:2062-2066(2008) [PubMed] [Europe PMC] [Abstract]
  34. "Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex."Proc. Natl. Acad. Sci. U.S.A. 105:4661-4666(2008) [PubMed] [Europe PMC] [Abstract]
  35. "Determination of the amino acid substitution in human prothrombin type 3 (157 Glu leads to Lys) and the localization of a third thrombin cleavage site."Br. J. Haematol. 54:245-254(1983) [PubMed] [Europe PMC] [Abstract]
  36. "Molecular defect of prothrombin Barcelona. Substitution of cysteine for arginine at residue 273."J. Biol. Chem. 261:15045-15048(1986) [PubMed] [Europe PMC] [Abstract]
  37. "Prothrombin Tokushima, a replacement of arginine-418 by tryptophan that impairs the fibrinogen clotting activity of derived thrombin Tokushima."Biochemistry 26:1117-1122(1987) [PubMed] [Europe PMC] [Abstract]
  38. "Prothrombin Tokushima: characterization of dysfunctional thrombin derived from a variant of human prothrombin."Blood 69:565-569(1987) [PubMed] [Europe PMC] [Abstract]
  39. "Identification of the primary structural defect in the dysthrombin thrombin Quick I: substitution of cysteine for arginine-382."Biochemistry 27:9160-9165(1988) [PubMed] [Europe PMC] [Abstract]
  40. "Substitution of valine for glycine-558 in the congenital dysthrombin thrombin Quick II alters primary substrate specificity."Biochemistry 28:2078-2082(1989) [PubMed] [Europe PMC] [Abstract]
  41. "Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity."Biochemistry 31:7457-7462(1992) [PubMed] [Europe PMC] [Abstract]
  42. "Prothrombin Himi: a compound heterozygote for two dysfunctional prothrombin molecules (Met-337-->Thr and Arg-388-->His)."Blood 80:2275-2280(1992) [PubMed] [Europe PMC] [Abstract]
  43. "Detection of a single base substitution of the gene for prothrombin Tokushima. The application of PCR-SSCP for the genetic and molecular analysis of dysprothrombinemia."Int. J. Hematol. 55:93-100(1992) [PubMed] [Europe PMC] [Abstract]
  44. "Prothrombin Padua I: incomplete activation due to an amino acid substitution at a factor Xa cleavage site."Blood Coagul. Fibrinolysis 5:841-844(1994) [PubMed] [Europe PMC] [Abstract]
  45. "Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala."Thromb. Haemost. 73:203-209(1995) [PubMed] [Europe PMC] [Abstract]
  46. "Characterization of single-nucleotide polymorphisms in coding regions of human genes."Nat. Genet. 22:231-238(1999) [PubMed] [Europe PMC] [Abstract]
  47. ErratumNat. Genet. 23:373-373(1999)
  48. "Quantitative detection of single amino acid polymorphisms by targeted proteomics."J. Mol. Cell Biol. 3:309-315(2011) [PubMed] [Europe PMC] [Abstract]